Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults
1 other identifier
interventional
26
1 country
1
Brief Summary
The aim of this randomized cross-over study was to determine the effects of legume consumption on adiponectin and inflammatory factors among first degree relatives of diabetic patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Sep 2012
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 25, 2013
CompletedFirst Posted
Study publicly available on registry
July 23, 2013
CompletedMay 20, 2014
May 1, 2014
4 months
June 25, 2013
May 16, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
high sensitive C reactive protein (mg/l)
amounts of hs-CRP
14 weeks
Secondary Outcomes (3)
Interleukin-6 (pg/ml)
14 weeks
Tumor necrosis factor-α (pg/ml)
14 weeks
Adiponectin (ng/ml)
14 weeks
Study Arms (2)
legume consumption
EXPERIMENTALlegume consumption, 4 servings per week, for 6 weeks
healthy dietary recommendations
ACTIVE COMPARATORno nutritional intervention
Interventions
Eligibility Criteria
You may qualify if:
- age more than 30 years
- no history of chronic diseases
- no use of blood glucose lowering drugs
You may not qualify if:
- do not use recommended amounts of legumes
- incidence of chronic diseases during the study
- to start use of blood glucose lowering drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Isfahan University of Medical Sciences
Isfahan, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Isfahan University of Medical Sciences
Study Record Dates
First Submitted
June 25, 2013
First Posted
July 23, 2013
Study Start
September 1, 2012
Primary Completion
January 1, 2013
Study Completion
March 1, 2013
Last Updated
May 20, 2014
Record last verified: 2014-05